| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 280 |
| 1 | PREDNISONE | 226 |
| 2 | VEDOLIZUMAB | 195 |
| 3 | METHOTREXATE SODIUM | 170 |
| 4 | METHOTREXATE | 154 |
| 5 | ACETAMINOPHEN | 133 |
| 6 | OMEPRAZOLE MAGNESIUM | 129 |
| 7 | ASPIRIN | 127 |
| 8 | ASPIRIN 325 MG | 121 |
| 9 | ASPIRIN 81 MG | 121 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROSE AND POTASSIUM CHLORIDE | 1 | 0.0588 |
| 1 | NEOSTIGMINE METHYLSULFATE | 10 | 0.0232 |
| 2 | ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE | 1 | 0.0169 |
| 3 | AMCINONIDE | 1 | 0.0118 |
| 4 | COAL TAR | 8 | 0.0101 |
| 5 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 6 | BUTORPHANOL TARTRATE | 2 | 0.0061 |
| 7 | NALDEMEDINE | 9 | 0.0054 |
| 8 | RASBURICASE | 12 | 0.0048 |
| 9 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 400 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 263 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 216 |
| 3 | Integrin Receptor Antagonist [EPC] | 206 |
| 4 | Benzodiazepine [EPC] | 164 |
| 5 | Proton Pump Inhibitor [EPC] | 158 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 154 |
| 7 | Kinase Inhibitor [EPC] | 142 |
| 8 | Vitamin C [EPC] | 131 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 130 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 2 | Provitamin D2 Compound [EPC] | 115 | 0.0039 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 6 | 0.0025 |
| 4 | Integrin Receptor Antagonist [EPC] | 206 | 0.0024 |
| 5 | Human Immunoglobulin G [EPC] | 38 | 0.0018 |
| 6 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 7 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 8 | Non-Standardized Insect Allergenic Extract [EPC] | 7 | 0.0012 |
| 9 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |